Verapamil Hydrochloride Injection, Solution
Product Images NDC 55150-342

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 55150-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-5 mg Per 2 mL (2.5 mg/ml) (Container Label)

The text provides information about a medication with NDC 55150-342-01 to be protected from light. It was manufactured in India for AuroMedics Pharma LLC in New Jersey. It's an injection with a concentration of 5 mg per 2 mL for intravenous use only. The code indicated is TS/DRUGS/13/2010 P1422944. The last line contains non-English characters and cannot be evaluated.*

FDA Label Image

Package Label-principal Display Panel-5 mg Per 2 mL (2.5 mg/ml) – Container-carton (1 Vial) (Verapamil Fig2)

This is a label for Verapamil HCI Injection, USP manufactured by Auromedics. Each 2 mL single dose vial contains 5 mg of Verapamil HCI injection, which is used for intravenous use only. The vial must be protected from light and stored at room temperature until ready to use. The stopper of the vial is not made of natural rubber latex. Dosage instructions are not available.*

FDA Label Image

Package Label-principal Display Panel-5 mg Per 2 mL (2.5 mg/ml) – Container-carton (5 Vials) (Verapamil Fig3)

Verapamil HCI Injection is a medicine with a dosage of 5mg per 2 mL (2.5mg/mL), packed in 5 x 2 mL single-dose vials. It should be used intravenously only and protected from light. It is distributed by AuoMedics Pharma LLC and its NDC number is 55150-342-05. The other parts of the given text are not readable.*

FDA Label Image

Package Label-principal Display Panel-5 mg Per 2 mL (2.5 mg/ml) – Container-carton (25 Vials) (Verapamil Fig4)

Verapamil Hydrochloride Injection, USP is a medication that is given through slow intravenous injection for the treatment of high blood pressure and angina. It contains 2.5 mg of verapamil hydrochloride in a 2 mL single-dose vial, which should be discarded if unused. The medication should be protected from light and stored at 20-25°C until ready to use. The usual dosage is determined by the healthcare provider. The vial stopper is not made with natural rubber latex. The product is for prescription-only use and was distributed by AuroMedics Pharma LLC located in New Jersey.*

FDA Label Image

Package Label-principal Display Panel-10 mg Per 4 mL (2.5 mg/ml) (Container Label)

This is a description of a medication in the form of an injection manufactured in India for AuroMedics Pharma LLC. The medication has a NDC code of 55150-343-01 and should be protected from light. The injection is 10mg per 4mL and is only intended for intravenous use. It comes in a single-dose vial.*

FDA Label Image

Package Label-principal Display Panel-10 mg Per 4 mL (2.5 mg/ml) – Container-carton (1 Vial) (Verapamil Fig6)

This is the description for a single dose vial of Verapamil Hydrochloride USP injection with a concentration of 10mg per 4ml (2.5mg/ml). It is intended for intravenous use only and must be protected from light. The contents of the vial contain verapamil hydrochloride USP, 25mg (equal to 23mg verapamil), sodium chloride, hydrochloric acid, and/or sodium hydroxide. The typical dosage is not mentioned, so the insert should be reviewed. The vial stopper is not made of natural rubber latex. The manufacturer is Auromedics and it is distributed by Auromedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel-10 mg Per 4 mL (2.5 mg/ml) – Container-carton (5 Vials) (Verapamil Fig7)

This text appears to contain product information for an injectable medication called ACTETEL T. The medication comes in single-dose vials of 4mL, with each vial containing 10mg of the medication per 4 mL. The medication is for intravenous use only and should be protected from light. The medication is distributed by AuroMedics Pharma and is manufactured in India. The text includes some additional information that is difficult to interpret due to scanning errors.*

FDA Label Image

Package Label-principal Display Panel-10 mg Per 4 mL (2.5 mg/ml) – Container-carton (25 Vials) (Verapamil Fig8)

This is a description of a medication called Verapamil HCI Injection. It is supplied in single-use vials containing 10 mg per 4 mL (2.5 mg/mL) of the medication. The injection should only be administered intravenously over a two-minute period of time. The usual dosage is not mentioned. The medication should be stored at 20° to 25°C (68° to 77°F). Verapamil HCI Injection should be protected from light until ready for use by retaining it in the carton. The vial stopper is not made with natural rubber latex. The text also includes information about the distributor of the medication.*

FDA Label Image

Chemical Structure (Verapamil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.